RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1136%2Fannrheumdis-2014-205698
https://w3id.org/ripe/ripe-kg/work/10.1136%2Fannrheumdis-2014-205698
| Subject | Predicate | Object |
|---|---|---|
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripe:concerns |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:publication-details/RIPEA49DCC9BA0CF06921Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripe:concerns |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:registry-evidence/RIPEA4875E56C8C5C4ACF |
ripe:concerns |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:registry-evidence/RIPEA49DCC9BA0CF06921 |
ripe:concerns |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:research-integrity-assessment/RIPEA4875E56C8C5C4ACF |
ripe:assesses |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:research-integrity-assessment/RIPEA49DCC9BA0CF06921 |
ripe:assesses |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:study-design-evidence/RIPEA4875E56C8C5C4ACF |
ripe:concerns |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:study-design-evidence/RIPEA49DCC9BA0CF06921 |
ripe:concerns |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
prism:doi |
10.1136/annrheumdis-2014-205698 |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:creator |
ripekg:author/RIPEAU38B001158B5DF270Ingemar Petersson |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:creator |
ripekg:author/RIPEAU390929084ABE0B3ELars Klareskog |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:creator |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:creator |
ripekg:author/RIPEAU49FEF77ABFD51CAEKristina Forslind |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:creator |
ripekg:author/RIPEAU91DA7E237F6DAE7FKarin Lundberg |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:creator |
ripekg:author/RIPEAUA13294C36BE9963FJohan Karlsson |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:creator |
ripekg:author/RIPEAUA88031F3AF121357Sofia Ernestam |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:creator |
ripekg:author/RIPEAUC60CA9E48FA30862Saedis Saevarsdottir |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:creator |
ripekg:author/RIPEAUC71ACAB9842E61F1Pierre Geborek |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:creator |
ripekg:author/RIPEAUC9051134F7DF008FAlf Kastbom |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:title |
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW1C3B44BE4FA6B17BHow to read radiographs according to the Sharp/van der Heijde method |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW24169F485707D0FAAvidity maturation of anticitrullinated protein antibodies in rheumatoid arthritis |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW29BC0F71FE1C984CAutoantibodies in early rheumatoid arthritis: Brasília cohort-results of a three-year serial analysis |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW3E49F4468BA7FCB4Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW4036C182E1594F67The influence of ACPA status and characteristics on the course of RA |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW4A9FC3039AEF3321Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW544AB2CA6AD88E5FMultiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW582F069ADADC2BB1Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW5CE5552A7FB26D55The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW612A584DE8F3F324Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW67404B34B1561BF3Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW7990D0F82744323BAntibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW7BB180F811A56C9DConventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW7FF80D63289C7502Antibodies to citrullinated alpha-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW80F04E5AE0750D75Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW91C6EDF0AA99CAE5Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWB26DBF22BD34DD24Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWB2BD2DADF0DB4143Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWBE3246AAA630654FGlycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWC749C2C461DBACDFThe ACPA recognition profile and subgrouping of ACPA-positive RA patients |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWDC95433AD9DAB249Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWDFCABBB7CB338B7DLongitudinal analysis of citrullinated protein/ peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWE25E3C5064B91DC9ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWE28553E5BB10E5B5Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF2F7DBE0AE047939Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF622686A0190FEF6Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF8F00317E4F2F0B6The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWFD322966B1089D28Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodies |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWFF0A6F6E3410EF8CSerological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWFF55786DDAE0B0F2Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
node1 |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
rdfs:Resource |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
owl:Thing |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
prov:Entity |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
owl:sameAs |
https://semopenalex.org/work/W2127173201 |